An Adherence Tool to Manage Narcotic -Addicted HIV Patients
Completed · Not applicable
Conditions studied: Healthy Adults
In brief
The purpose of this study is to develop a cost-effective breath-based medication adherence monitoring system that can monitor whether recovering opiate addicts actually take a specific treatment medication called naltrexone.
Key facts
- Study ID
- NCT02194764
- Run by
- Xhale Assurance
- People needed
- 8
- Starts
- 2014-06-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2014-07-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ability to understand and provide written informed consent
- Subject is at least 18 Years of Age
- Subject must be willing to comply with study procedures
You may not qualify if…
- <18 years
- Subject has a history of opioid use disorder
- current chronic opioid therapy or recent (past week) acute opioid therapy,
- currently pregnant
- contraindications to naltrexone use per FDA label.
Where it is running
- University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.